BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36226635)

  • 1. Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Children, Adolescents, and Young Adults.
    Tian T; Huang S; Dai H; Qi M; Liu B; Huang R
    J Clin Endocrinol Metab; 2023 Jan; 108(2):306-314. PubMed ID: 36226635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower
    Meng Z; Matsuse M; Saenko V; Yamashita S; Ren P; Zheng X; Jia Q; Tan J; Li N; Zheng W; Zhao L; Mitsutake N
    IUBMB Life; 2019 Jul; 71(7):1030-1040. PubMed ID: 31026111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.
    Mu Z; Zhang X; Sun D; Sun Y; Shi C; Ju G; Kai Z; Huang L; Chen L; Liang J; Lin Y
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1231-1240. PubMed ID: 38060243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Shobab L; Gomes-Lima C; Zeymo A; Feldman R; Jonklaas J; Wartofsky L; Burman KD
    Thyroid; 2019 Sep; 29(9):1262-1268. PubMed ID: 31319763
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with
    Zhang XY; Song HJ; Qiu ZL; Shen CT; Chen XY; Sun ZK; Wei WJ; Zhang GQ; Luo QY
    Endocrine; 2018 Oct; 62(1):149-158. PubMed ID: 30022382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical association of CXCR4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment.
    Sirakriengkrai K; Tepmongkol S; Keelawat S; Techavijit U
    Nucl Med Commun; 2021 Apr; 42(4):396-401. PubMed ID: 33306632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy.
    Liu W; Jiang B; Xue J; Liu R; Wei Y; Li P
    Ann Diagn Pathol; 2024 Apr; 69():152243. PubMed ID: 38128440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers.
    Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
    Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
    [No Abstract]   [Full Text] [Related]  

  • 10. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
    Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
    Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    Wang C; Zhang X; Li H; Li X; Lin Y
    PLoS One; 2017; 12(7):e0179664. PubMed ID: 28704384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
    Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
    Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer.
    Liu L; Shi Y; Lai Q; Huang Y; Jiang X; Liu Q; Huang Y; Xia Y; Xu D; Jiang Z; Tu W
    Front Endocrinol (Lausanne); 2022; 13():865909. PubMed ID: 35634509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
    Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
    Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
    Mihailovic J; Stefanovic L; Malesevic M; Markoski B
    Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
    Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
    ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.
    de la Fouchardiere C; Oussaid N; Derbel O; Decaussin-Petrucci M; Fondrevelle ME; Wang Q; Bringuier PP; Bournaud-Salinas C; Peix JL; Lifante JC; Giraudet AL; Lopez J; Borson-Chazot F
    Target Oncol; 2016 Feb; 11(1):71-82. PubMed ID: 26285789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.